Viewing Study NCT03006367


Ignite Creation Date: 2025-12-25 @ 12:40 AM
Ignite Modification Date: 2026-01-10 @ 2:27 PM
Study NCT ID: NCT03006367
Status: COMPLETED
Last Update Posted: 2021-07-06
First Post: 2016-12-22
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Pharmacokinetic and Tolerability Study of NFC-1 in Subjects Aged 6-17 Years With ADHD
Sponsor: Aevi Genomic Medicine, LLC, a Cerecor company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module